Herlev, Denmark

Anders Robert Sørensen



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator of Health: Anders Robert Sørensen and His Single-Chain Insulin Patent

Introduction: Anders Robert Sørensen, located in Herlev, Denmark, is an accomplished inventor recognized for his significant contributions to the field of biochemistry. With one patent to his name, Sørensen is leading innovations that are set to transform diabetes treatment.

Latest Patents: Sørensen's notable invention revolves around a unique formulation of single-chain insulin. This advancement features insulin activity that comprises a B- and A-chain connected by a connecting peptide containing 6-11 amino acids. The innovation ensures that these single-chain insulins display biological insulin activity and have an affinity for the IGF-1 receptor that is comparable to or lower than that of human insulin. Importantly, these formulations also boast high physical stability and may even incorporate one or more basic amino acid residues in the connecting peptide, with acylation possible at Lys residues.

Career Highlights: Currently, Anders Robert Sørensen works at Novo Nordisk A/S, a leading global healthcare company known for its strong focus on diabetes care and innovative medicines. His work at this institution is complemented by a profound understanding of biochemistry and insulin mechanisms.

Collaborations: Within his professional sphere, Sørensen collaborates with notable coworkers such as Thomas Børglum Kjeldsen and Morten Schlein. Their combined expertise contributes significantly to the research and development undertaken at Novo Nordisk A/S, fostering an environment where groundbreaking innovations can thrive.

Conclusion: Anders Robert Sørensen exemplifies the spirit of innovation in the biopharmaceutical industry. With his pioneering patent on single-chain insulin, he is contributing to the advancement of diabetes treatment, showcasing how dedicated inventors can effect positive change in global health. Through continuous collaboration and research, Sørensen and his team at Novo Nordisk A/S are paving the way for a brighter future in diabetes management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…